https://www.selleckchem.com/pr....oducts/rg2833-rgfp10
w. Treatment guidelines for chronic hepatitis B (CH do not recommended antiviral therapy for patients in the immune-tolerant phase of the disease, which generally occurs in children who acquire hepatitis B virus (HBV) vertically and may last for decades. On the basis of promising results of a pilot study, we conducted a randomized, controlled, multicenter study to evaluate the efficacy and safety of antiviral therapy in children and adolescents with immune-tolerant CHB. Fifty-nine children aged 3 to 18 years HBe antigen-pos
Like
Comment
Share
